Crossmark

Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy Volunteers

Published Online: 2020-05-05

Published Print: 2020-06

Authors

Ollier, Celine

Sent, Ulrike

Mesquita, Margarida

Michel, Martin C.
Funding

Funding for this research was provided by:

Sanofi Aventis

Boehringer Ingelheim
License Information

Text and Data Mining valid from 2020-05-05

Version of Record valid from 2020-05-05
More Information

Article History

Received: 28 February 2020

First Online: 5 May 2020

Document is current